MedPoint News

Bone marrow study collects breath, blood samples from astronauts to better the health care of patients and space travellers alike.

This is the first time both organizations will take part in this event that gives the public access to buildings they might not otherwise have a chance to see.

The Ontario Institute of Cancer Research (OICR) has awarded $4 million to a team of researchers working to harness the immune system to attack cancer.

A group of uOttawa researchers have shed new light on what motivates people to seek help. The answer, they found, lies with family and friends.

Assistant professor Dr. Garth Nicholas is part of new clinical trials to determine if an experimental therapy combining two viruses and a drug may be able to treat non-small cell lung cancer.

The Gairdners, nicknamed the “baby Nobels,” are awarded every year to seven of the world’s most creative and accomplished biomedical scientists.

A new study led by Dr. Catherine Pound, a pediatrician at CHEO and assistant professor at the University of Ottawa, has led to an 18% decrease in length of stay for children admitted to the hospital with severe asthma.

uOttawa Faculty of Medicine and the Canadian Agency for Drugs and Technologies in Health (CADTH) have teamed up to host a public event marking the release of the fourth edition of the Guidelines for the Economic Evaluation of Health Technologies: Canada.

An international research team with prominent Canadian leadership has found blood thinner rivaroxaban to be more effective at preventing recurrence of life-threatening blood clots.

A new workshop report, Building on Canada’s Strengths in Regenerative Medicine, released recently by the Council of Canadian Academies (CCA), confirms that Canadian researchers continue to be recognized as scientific leaders in the field of regenerative medicine and stem cell science.

The Faculty of Medicine anticipates that the sharing of lab space will enhance the collaborative efforts between neuroscientists of uOttawa and Carleton University.

Recent study out of the University of Ottawa opens door for new disease therapies in cancer, ALS, Fragile X Syndrome and others.

Professor Yao’s unique work has been featured in a University-wide campaign.

A promising combination of immunotherapies delivers a one-two punch to brain cancer tumours with high cure rates in mice, scientific evidence published in Nature Communications today says.

An award-winning study by a uOttawa prof demonstrates the effectiveness of youth education in shaping attitudes toward mental health issues.